Cited by 201Computational Drug Discovery MethodsSynthesis and Characterization of Heterocyclic CompoundsGraph theory and applications

SAR Index: Quantifying the Nature of Structure−Activity Relationships

Peltason, Lisa, Bajorath, Jürgen·2007·Journal of Medicinal Chemistry

Abstract

Structure-activity relationships (SARs) can display very different features. Small chemical modifications of active molecules often dramatically alter biological responses. By contrast, structurally diverse molecules can have similar activity. SARs can also be heterogeneous in nature. For example, for structurally diverse molecules with similar activity, closely related analogs might have significant differences in potency. Given the inherent complexity of SARs, it has been very difficult to estimate SAR characteristics from molecular structure. On the basis of systematic correlation of 2D structural similarity and compound potency, we have developed a function termed "SAR Index" that quantitatively describes the nature of SARs and establishes different SAR categories: continuous, discontinuous, heterogeneous-relaxed, and heterogeneous-constrained. These heterogeneous SAR categories are described for the first time. Given a set of active compounds and their potency values, SAR Index calculations can estimate how likely it is to identify structurally distinct molecules having similar activity.

Integrity signals

Registry

Crossref · 10.1021/jm0705713

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SAR discontinuities occur when small structural modifications lead to very large biological potency changes, not consistent with the similarity-property principle and falling outside the applicability domain of linear QSAR models.

    “In contrast, SAR discontinuities21 occur when small structural modifications lead to very large biological potency changes, not consistent with the SPP and falling outside the applicability domain of linear QSAR models.”

    From QSAR without borders (2020) · cites this paper as [21]

  • In QSAR modeling the presence of SAR continuities and discontinuities in sets of active compounds is not mutually exclusive; continuous and discontinuous SARs coexist in many data sets.

    “In QSAR modeling the presence of SAR continuities and discontinuities in sets of active compounds is not mutually exclusive. Rather, continuous and discontinuous SARs coexist in many data sets21 resulting in the presence of adjacent gently sloped and rugged regions in activity landscapes (Figure 2).”

    From QSAR without borders (2020) · cites this paper as [21]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Peltason, L., & Bajorath, J.
Affiliations
University of Bonn (DE)
Corresponding author
Bajorath, Jürgen
Venue
Journal of Medicinal Chemistry
Published
2007-09-29
Volume
50
Issue
23
Pages
5571-5578
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2034541070
Cited by
201
References
6
Citations by year
2026: 7 · 2025: 16 · 2024: 7 · 2023: 4 · 2022: 10 · 2021: 6 · 2020: 8 · 2019: 3 · 2018: 8 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 11 · 2013: 16 · 2012: 18
FWCI
19.09
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
  • Physical Sciences › Mathematics › Geometry and Topology › Graph theory and applications
Keywords
structure-activity relationship
MeSH terms
Adenosine Deaminase, Carbonic Anhydrases, Data Interpretation, Statistical, Enzyme Inhibitors, Ribonuclease, Pancreatic, Thromboxane-A Synthase, Thymidylate Synthase, Factor Xa, Quantitative Structure-Activity Relationship, Adenosine Deaminase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review